Cyclo Therapeutics, Inc. (CYTH) has a market capitalization of $23.59M and trades at $0.72. The 52-week range is 0.55-1.6199.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-1.23, annual revenue of $1.08M.
The stock has a beta of -0.57, operates in the Healthcare sector.
